Director, Statistical Programming
Kardigan
Director, Statistical Programming
Kardigan
Biotech firm developing cardiovascular medicines
About Us
Position Title: Director, Statistical Programming
Department: Clinical Data Sciences & Analytics
Reports To: Head of Statistical Programming
Location: South San Francisco, CA or Princeton, NJ – On-site 4 days per week (Mon to Thurs)
Job Overview:
The Director of Statistical Programming will serve as the compound lead, responsible for programming strategy and delivery across all studies and integrated analyses for an assigned compound. This role will build and lead a team of statistical programmers and oversee internal and outsourced programming activities, ensuring quality, consistency, and timely delivery of clinical reporting and regulatory submission deliverables, while providing technical leadership and remaining hands-on in SAS/R for complex programming and technical review as needed.
This position will serve as the primary Statistical Programming representative on compound teams, partnering with Biostatistics and Clinical Data Management (CDM) to align data collection, analysis requirements, and programming plans. The compound lead will establish consistent programming standards across studies, coordinate resources and timelines, and proactively address delivery risks. Additionally, this position will contribute to establishing SOPs and programming standards and modernizing statistical reporting with open-source tools.
ESSENTIAL DUTIES AND RESPONSIBILITIES
Key Project Responsibilities:
Initiative Responsibilities:
Qualifications and Preferred Skills
Education:
Experience and Skill Set:
Exact Compensation may vary based on skills, experience and location.
Pay range 183000 - 250000 USD
Kardigan develops medicines to prevent and treat cardiovascular disease. It focuses on discovering and developing multiple cardiovascular therapies at a rapid pace, using deep expertise in heart-health drug development to move candidates from research toward commercialization. Their product approach centers on creating medicines that address heart disease more effectively and earlier in the disease process. Kardigan differentiates itself through a leadership team of seasoned biopharma veterans and a commitment to modernizing how cardiovascular drugs are discovered and developed, aiming to bring therapies to patients faster and more efficiently. The company’s goal is to reduce the global burden of cardiovascular disease by providing safe, effective medicines that prevent progression or cure conditions related to heart health.
Explore more opportunities at Kardigan